Neonatal tetanus is a form of tetanus that affects newborns, typically within the first few days of life. It occurs when tetanus spores contaminate the umbilical stump, especially in unhygienic birth practices. Neonatal tetanus is a significant global health concern, particularly in regions with limited access to healthcare and vaccination. Efforts to eliminate neonatal tetanus involve maternal immunization during pregnancy with tetanus toxoid-containing vaccines. This strategy, known as maternal and neonatal tetanus (MNT) elimination, aims to provide immunity to pregnant women, preventing the transmission of tetanus to their newborns. The World Health Organization (WHO) and UNICEF lead global initiatives to eliminate MNT, working with countries to strengthen vaccination programs and improve maternal and neonatal healthcare practices. Global progress in tetanus elimination has been substantial, with many countries achieving MNT elimination status. However, challenges persist in reaching vulnerable populations, particularly in conflict zones or areas with weak healthcare infrastructure. Ongoing efforts focus on sustaining and expanding immunization coverage, enhancing surveillance, and ensuring access to clean delivery practices.
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : Changing population immunity to COVID-19 in the context of infection, vaccination, and emerging SARS-CoV-2 variants
Ranjan Ramasamy, ID-FISH Technology, United States
Title : From bench to preclinical evaluation: LL-37-derived peptides for combating orthopedic infections
Vincenzo Pennone, IRCCS Galeazzi Sant’Ambrogio Hospital, Italy
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030
Pedro Plans Rubio, College of Physicians of Barcelona, Spain
Title : Personalized and precision medicine (PPM) as a unique healthcare model to se-cure the human healthcare, wellness and biosafety through the view of public health, network driven healthcare services and lifestyle management
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation